<code id='773FE75704'></code><style id='773FE75704'></style>
    • <acronym id='773FE75704'></acronym>
      <center id='773FE75704'><center id='773FE75704'><tfoot id='773FE75704'></tfoot></center><abbr id='773FE75704'><dir id='773FE75704'><tfoot id='773FE75704'></tfoot><noframes id='773FE75704'>

    • <optgroup id='773FE75704'><strike id='773FE75704'><sup id='773FE75704'></sup></strike><code id='773FE75704'></code></optgroup>
        1. <b id='773FE75704'><label id='773FE75704'><select id='773FE75704'><dt id='773FE75704'><span id='773FE75704'></span></dt></select></label></b><u id='773FE75704'></u>
          <i id='773FE75704'><strike id='773FE75704'><tt id='773FE75704'><pre id='773FE75704'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:comprehensive    Page View:66171
          The building exterior of AstraZeneca, a pharmaceutical and biopharmaceutical company, under cloudless blue sky — coverage from STAT
          Adobe

          WILMINGTON, Del. — Wednesday was the first time that a federal judge asked questions in-person of drug industry lawyers who are trying to stop Medicare from negotiating drug prices. It didn’t go well for them.

          AstraZeneca’s lawyers argued that Medicare’s new powers amount to a taking of their property rights without due process. But Colm Connolly, chief judge of the U.S. District Court of Delaware, said he doesn’t understand how the law deprives AstraZeneca of its property. He asked Catherine Stetson, who represents AstraZeneca, multiple times to explain what property the company would lose due to Medicare price negotiation. Stetson said it’s both the patent and the drug that’s subject to the patent.

          advertisement

          “You’re free to do what you want,” Connolly said, adding that drug companies don’t have to sell to Medicare. “You may not make as much money.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          What past blockbusters can tell us about future of Wegovy and other weight loss medicines
          What past blockbusters can tell us about future of Wegovy and other weight loss medicines

          MollyFergusonforSTATThenewsthattheweightlossdrugWegovyreducedtheriskofheartattacksandstrokesinoverwe

          read more
          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more

          Trans patients at the end of life deserve respect and dignity

          JohnMoore/GettyImagesIntheUnitedStates,morethan1.6millionpeopleidentifyastransgender.Ofthese,moretha